🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trials studies how well pembrolizumab and vactosertib work af...
Status
Terminated
Location
University of California, San Francisco
Start Date
2019-07-22
Trial ID
NCT03844750
Treatments Being Tested
This multi-institutional, phase 2 clinical trial is studying two doses of p...
Status
Completed
Location
Mayo Clinic
Start Date
2017-01
Trial ID
NCT02818920
Treatments Being Tested
The purpose of this study is to determine safety and preliminary efficacy o...
Status
Recruiting
Location
University of California at San Diego Moores Cancer Center
Start Date
2024-04-22
Trial ID
NCT06385080
Treatments Being Tested
The purpose of this study is to evaluate anti-PD-1 Neoadjuvant therapy in B...
Status
Completed
Location
Cleveland Clinic, Case Comprehensive Cancer Center
Start Date
2020-08-04
Trial ID
NCT04323202
Treatments Being Tested
This is a phase II study to assess the efficacy, safety, and Health Related...
Status
Recruiting
Location
Ryan Nguyen
Start Date
2022-12-28
Trial ID
NCT05613413
Treatments Being Tested
This phase II trial tests whether panitumumab and pembrolizumab in combinat...
Status
Withdrawn
Location
M D Anderson Cancer Center
Start Date
2022-03-11
Trial ID
NCT05177796
Treatments Being Tested
Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab follo...
Status
Recruiting
Location
Baylor College of Medicine
Start Date
2022-08-31
Trial ID
NCT05132504
Treatments Being Tested
TNBC is a heterogeneous disease with distinct pathological, genetic, and cl...
Status
Not Yet Recruiting
Location
SLK-Kliniken Heilbronn GmbH, Klinik für Gynäkologie und Geburtshilfe
Start Date
2026-08-30
Trial ID
NCT07178730
The majority of head and neck cancer patients do not respond to immunothera...
Status
Active Not Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2024-02-23
Trial ID
NCT05787639
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of pembrol...
Status
Recruiting
Location
Department of minimally invasive esophageal surgery, Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-12-01
Trial ID
NCT04807673
Treatments Being Tested